| 000 | 00988 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250512035255.0 | ||
| 264 | 0 | _c19880620 | |
| 008 | 198806s 0 0 eng d | ||
| 022 | _a0266-9536 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSigal, I S | |
| 245 | 0 | 0 |
_aMolecular approaches towards an anti-ras drug. _h[electronic resource] |
| 260 |
_bAnti-cancer drug design _cOct 1987 |
||
| 300 |
_a107-15 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
| 650 | 0 | 4 | _aComputer Simulation |
| 650 | 0 | 4 |
_aGTP-Binding Proteins _xanalysis |
| 650 | 0 | 4 | _aModels, Structural |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins _xanalysis |
| 650 | 0 | 4 | _aProto-Oncogene Proteins p21(ras) |
| 700 | 1 | _aSmith, G M | |
| 700 | 1 | _aJurnak, F | |
| 700 | 1 | _aMarsico-Ahern, J D | |
| 700 | 1 | _aD'Alonzo, J S | |
| 700 | 1 | _aScolnick, E M | |
| 700 | 1 | _aGibbs, J B | |
| 773 | 0 |
_tAnti-cancer drug design _gvol. 2 _gno. 2 _gp. 107-15 |
|
| 999 |
_c3135868 _d3135868 |
||